Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00626366 · ClinicalTrials.gov registry record · NA
Distribution of Topical Nasal Medication Within the Nasal Cavity and Sinuses by Radiographic Comparison
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT00626366 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 18 participants.
The verdict
NCT00626366, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the distribution of nasal sprays and nasal drops when used.
Interventions
- RADIATION Sinus CT Scan
- DRUG Omnipaque 240 Contrast Solution
- DRUG Omnipaque 240 mg I/mL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2008-03-12 |
| Est. Completion | 2009-01-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00626366
The ClinicalTrials.gov registry entry for NCT00626366 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sinus CT Scan is the first listed.
NCT00626366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00626366 about?
NCT00626366 is a clinical study titled "Distribution of Topical Nasal Medication Within the Nasal Cavity and Sinuses by Radiographic Comparison". The purpose of this study is to determine the distribution of nasal sprays and nasal drops when used.
What is the current status of trial NCT00626366?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2008-03-12. Estimated completion is 2009-01-09.
What interventions are being tested in trial NCT00626366?
The interventions under investigation include: Sinus CT Scan (RADIATION), Omnipaque 240 Contrast Solution (DRUG), Omnipaque 240 mg I/mL (DRUG).
Who is sponsoring clinical trial NCT00626366?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.